2011
DOI: 10.1016/j.biomaterials.2010.11.005
|View full text |Cite
|
Sign up to set email alerts
|

The labeling of cationic iron oxide nanoparticle-resistant hepatocellular carcinoma cells using targeted magnetoliposomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
23
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 37 publications
(26 citation statements)
references
References 45 publications
(56 reference statements)
3
23
0
Order By: Relevance
“…Upon incubating the cells with 15 nM QDots, which is a typical QDot concentration used for cell labeling [18], confocal microscopy revealed endolysosomal localization of the QDots in all three cell types ( Figure 1A) as is commonly observed for NPs [32][33][34]. For endosomal visualization, the lipophilic dye 3,3′-dioctadecyloxacarbocyanine perchlorate (DiO) was used.…”
Section: Resultsmentioning
confidence: 82%
“…Upon incubating the cells with 15 nM QDots, which is a typical QDot concentration used for cell labeling [18], confocal microscopy revealed endolysosomal localization of the QDots in all three cell types ( Figure 1A) as is commonly observed for NPs [32][33][34]. For endosomal visualization, the lipophilic dye 3,3′-dioctadecyloxacarbocyanine perchlorate (DiO) was used.…”
Section: Resultsmentioning
confidence: 82%
“…The uptake of ZDS-coated NPs is lower than (but comparable to) that 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 observed for well dispersed iron oxide NPs coated with PEG 600 carboxylic acid 34 and for anionic magnetoliposomes. 30 Iron oxide NPs (11 nm) coated with dimercaptosuccinic acid showed slightly lower uptake with respect to our ZDS-coated NPs. 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 destiny of NPs could actually represent a great advantage in cancer therapy as lysosomaltargeted magnetic NPs were recently reported ...…”
Section: Acs Paragon Plus Environmentmentioning
confidence: 86%
“…HepG2 cells were previously used to evaluate the biocompatibility and uptake of iron oxide NPs with different coating. [30][31][32][33][34][35] To investigate the intracellular fate of NPs, we used iron oxide NPs coated with a mixture of ZDS and a fluorescein derivative (FLC) possessing a catecholic terminal for grafting to the NPs.…”
Section: Introductionmentioning
confidence: 99%
“…Soenen et al have used magnetoliposomes that contained galactose-terminal phospholipids to promote specific uptake via asialoglycoprotein receptors. 108,109 These receptors are over-expressed on hepatocytes and hepatocyte-like cells so that systemic administration of those functionalized magnetoliposomes would allow the specific visualization of hepatocytes. 109 …”
Section: Mri Contrast Agents Targeting Specific Cell Typesmentioning
confidence: 99%